Sunday - January 11, 2026
Senator Collins Questions Merck CEO on Prescription Drug Affordability
February 09, 2024
WASHINGTON, Feb. 9 -- Sen. Susan M. Collins, R-Maine, issued the following news release:

Click HERE to watch Senator Collins' Q&A with CEO of Merck & Co. Robert Davis and HERE to download.

Washington, D.C. - Yesterday, at a Senate Health Committee hearing with CEOs of major drug manufacturers, U.S. Senator Susan Collins questioned CEO of Merck & Co., Robert Davis, on efforts pharmaceutical companies are taking to continue innovating new medications whil . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products